bendamustine hydrochloride has been researched along with Nephrotic Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantarovich, D; Delaunay, J; Kandel, C; Ville, S | 1 |
| Bourne, H; Sayer, JA; Willows, J; Wood, K | 1 |
| Biryukova, LS; Dzhumabaeva, BT; Golitsyna, EP; Varshavsky, VA | 1 |
| Bartel, C; Geiger, H; Hauser, IA; Obermüller, N; Rummel, MJ | 1 |
4 other study(ies) available for bendamustine hydrochloride and Nephrotic Syndrome
| Article | Year |
|---|---|
IgGκ light and heavy chain amyloidosis secondary to a B-cell lymphoproliferative disorder, whole picture on a renal biopsy.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bendamustine Hydrochloride; Biomarkers; Biopsy; Cell Proliferation; Humans; Immunoglobulin Heavy Chains; Immunoglobulin kappa-Chains; Immunoglobulin Light-chain Amyloidosis; Lymphoma, B-Cell, Marginal Zone; Male; Nephrotic Syndrome; Rituximab; Treatment Outcome | 2020 |
Acquired C1-inhibitor deficiency presenting with nephrotic syndrome.
Topics: Aged; Angioedemas, Hereditary; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Humans; Male; Nephrotic Syndrome; Quality of Life; Return to Work; Rituximab; Treatment Outcome; Waldenstrom Macroglobulinemia | 2019 |
[Minimal-change glomerulonephritis in chronic lymphocytic leukemia: A clinical case].
Topics: Antineoplastic Agents; Bendamustine Hydrochloride; Female; Glomerulonephritis; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Nephrotic Syndrome; Rituximab | 2015 |
Remission of a B cell CLL-associated membranoproliferative glomerulonephritis Type I with rituximab and bendamustine.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Bendamustine Hydrochloride; Drug Therapy, Combination; Glomerulonephritis, Membranoproliferative; Humans; Immunologic Factors; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Nephrotic Syndrome; Nitrogen Mustard Compounds; Remission Induction; Rituximab | 2008 |